New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease
A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to the Commission, working alongside...
New study aims to improve liver health after menopause
Researchers from Imperial College London will look at a treatment called kisspeptin. They hope to find out if it has health benefits for post menopause women with signs of MASLD. After menopause, hormone changes can raise the risk of health issues. One of these is a...
Recreating metabolic liver disease in the lab: how the MIMIC project could change MASLD research
One of the most common causes of chronic liver disease in the UK is MASLD. This stands for metabolic dysfunction‑associated steatotic liver disease. It was previously known as non-alcoholic fatty liver disease or NAFLD. MASLD is closely linked to obesity and type 2...